Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course

Journal of Rheumatology

Volumn 30, Issue 6, 2003, Pages 1272-1276

  Liozon, Eric ^a   Boutros Toni, Fernand ^b   Ly, Kim ^b   Loustaud Ratti, Véronique ^b   Soria, Pascale ^b   Vidal, Elisabeth ^b  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Constitutional symptoms inflammatory response; Fever of unknown origin; Temporal arteritis; Visual risk

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PRIORITY JOURNAL; TEMPORAL ARTERITIS; TREATMENT OUTCOME; VASCULITIS; VISUAL IMPAIRMENT;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; FEMALE; FEVER OF UNKNOWN ORIGIN; HUMANS; MALE; PREDNISONE; RISK FACTORS; TEMPORAL ARTERITIS; TREATMENT OUTCOME;

EID: 0038657572     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Goodman BW. Temporal arteritis. Am J Med 1979;67:839-52.
2. Healey LA, Wilske KR. Presentation of occult giant cell arteritis. Arthritis Rheum 1980;23:641-3.
3. Weiss M, Gonzalez E, Miller SB, Agudelo CA. Severe anemia as the presenting manifestation of giant cell arteritis. Arthritis Rheum 1995;38:434-6.
4. Ghose MK, Shensa S, Lerner PI. Arteritis of the aged (giant cell arteritis) and fever of unexplained origin. Am J Med 1976; 60:429-35.
5. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undeterminated origin. Arthritis Rheum 1981;24:1414-8.
6. Malvalm BE, Bengtsson BA, Alestig K, Bojs G, Iwarson S. The clinical pictures of giant cell arteritis: temporal arteritis, polymyalgia rheumatica and fever of unknown origin. Postgrad Med J 1980;67:141-8.
7. Desmet GD, Knockaert DC, Bobbaers HJ. Temporal arteritis: the silent presentation and delay in diagnosis. J Intern Med 1990;227:237-40.
8. Harrison MJG, Bevan AT. Early symptoms of temporal arteritis. Lancet 1967;2:638-43.
9. Hunder GG, Bloch BA, Michel DA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
10. Huston K, Hunder GG, Lie JT, Kennedy RH, Elvebach LR. Temporal arteritis. A 25-year epidemiologic, clinical and pathologic study. Ann Intern Med 1978;88:162-7.
11. Simmons RJ, Cogan DG. Occult temporal arteritis. Arch Ophthalmol 1962;68:38-48.
12. Hayreh SS. Masticatory muscle pain: an important indicator of giant cell arteritis. Spec Care Dentist 1998;18:60-5.
13. Bird HAW, Essenlick AJ, Dixon AJ, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
14. Klein RG, Hunder GG, Sanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975;83:806-12.
15. De Kleijn EMHA, Vandenbroucke JP, Van Der Meer JWM, and The Netherlands FUO Study Group. Fever of unknown origin (FUO). I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine (Baltimore) 1997;76:392-400.
16. Petersdorf RG, Beeson PB. Fever of unknown origin: report of 100 cases. Medicine 1961;40:1-30.
17. Hamilton CR, Shelley WM, Tumulty PA. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine (Baltimore) 1971;50:1-27.
18. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Arthritis Rheum 1998;41:1497-504.
19. Nesher G, Sonnenblick M. No association between the inflammatory response and the risk of developing irreversible cranial ischemic complications: comment on the article by Cid, et al [letter]. Arthritis Rheum 1998;41:2088-9.
20. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79:383-92.
21. Machado EBV, Michet CJ, Ballard DJ, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-9.
22. Gonzalez-Gay MA, Blanco R, Sanchez-Andrade A, Vazquez-Caruncho M. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features. J Rheumatol 1997;24:2166-70.
23. Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980. Medicine (Baltimore) 1982;61:269-92.
24. Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 1992;152:51-5.
25. Lortholary O, Guillevin L, Bletry O, Godeau P. Fever of unknown origin: a retrospective multicentric study of 103 cases, 1980-1988. Eur J Intern Med 1992;3:109-20.
26. Esposito AL, Gleckman R. Fever of unknown origin in the elderly. J Am Geriatr Soc 1978;26:498-505.
27. Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc 1993;41:1187-92.
28. Knockaert DC, Vanneste LJ, Bobbaers HJ. Recurrent or episodic fever of unknown origin. Review of 45 cases and survey of the literature. Medicine 1993;72:184-96.
29. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995;24:422-31.
30. Atalay MK, Bluemke DA. Magnetic resonance imaging of large vessel vasculitis. Curr Opin Rheumatol 2001;13:41-7.
31. Stanson AW. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000;18 Suppl 20:S43-8.
32. Blockmans D, Maes A, Stroobants S, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology 1999;38:444-7.
33. Turlakow A, Yeung HW, Pui J, et al. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 2001;161:1003-7.
34. Liozon E, Herrmann FR, Ly K, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 2001;111:211-7.
35. Hollenhorst RW, Brown JR, Wagener HP. Neurologic aspects of temporal arteritis. Neurology 1960;10:490-8
36. Font C, Cid MC, Coll-Vinent B, Lopez-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsyproven giant cell arteritis. Br J Rheumatol 1997;36:251-4.
37. Cid MC, Font C, Oristrell J, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998;41:26-32.
38. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998;125:509-20.
39. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994;101:1779-85.
40. Strachan RW, How J, Bewsher PD. Masked giant cell arteritis. Lancet 1980;1:194-6.
41. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
42. Kaiser M, Weyand CM, Bjornsson J, Goronzy JJ. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998;41:623-33.
43. Kaiser M, Younge B, Bjornsson J, Goronzy JJ, Weyand CM. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999;155:765-74.
44. Weyand CM. The pathogenesis of giant cell arteritis. J Rheumatol 2000;27:517-22.
45. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311-7.